Authors


Jacob A. Rogers

Latest:

Study compares postoperative refractive accuracy of formula-modified keratometry values versus total keratometry values obtained by a swept-source OCT biometer with new-generation multivariable IOL calculation formulas

Older generation non-LVC formulas show marked improvement upon using TK values vs K, while multivariable non-LVC formulas did not consistently improve.


Jella An, MD

Latest:

Netarsudil provides IOP lowering in goniotomy treated eyes

The unique MOA may deliver a synergistic effect when prescribed post-surgically.


Andrew R. Harrison, MD

Latest:

Advancement in TED treatment is a bright spot

FDA approval of teprotumumab as therapeutic offers hope for patients.


Gerald J. Roper, MD

Latest:

Protecting cataract patients and their surgeons' practices

Maximizing refractive surgery is key to ensuring prosperous future


Steven A. Greenstein, MD

Latest:

IKA Keratoconus Symposium 2023: New data presented for epi-on cross-linking

John D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.



Sydney M Crago

Latest:

Ocutrx Technologies' OcuLenz: A new augmented reality headset to enhance the visual clarity for patients who have advanced macular degenerations

The augmented reality headset compensates for central vision loss to enhance the visual clarity of patients with age-related macular degeneration and other conditions such as Stargardt disease.


Nancy Holekamp, MD

Latest:

ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTS

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.


Marco Mura, MD

Latest:

Managing neovascular retinal disease in COVID-19 era requires careful approach

Minimizing clinic visits, maximizing use of imaging modalities are key.


Karl Stonecipher, MD

Latest:

Final Pearls on Managing Dry Eye Patients With Comorbidities

Ophthalmologists end their discussion on the management of dry eye disease with other ocular comorbidities highlighting key takeaways and prospective advances in care and outcomes.


Mark T. Dunbar, OD, FAAO

Latest:

ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTS

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.


Samir N. Patel, MD

Latest:

Focusing on postinjection endophthalmitis

Systemic immunosuppression may prevent devastating complication in patients.



Victor H. Gonzalez, MD

Latest:

Seize underutilized opportunity to treat glaucoma during vitrectomy

Ophthalmologists can reduce IOP and medications with endocyclophotocoagulation while in the eye.


Marta Ibarz Barberá, MD

Latest:

Benefits of topography-guided treatments for irregular corneas

Procedure can improve best-corrected visual acuity, enhancing quality of life for patients.


Carl D. Regillo, MD, FACS, FASRS

Latest:

Considerations for the Future of Biosimilars in the Treatment of Retinal Disorders

Carl D. Regillo, MD, and Jennifer I. Lim, MD, emphasize the high regulatory standards of equivalence and safety of biosimilars in considering the role they will play in the evolving treatment landscape for retinal disorders.


Dilraj S. Grewal, MD

Latest:

Weighing treatments for chronic postop cystoid macular edema

Prompt and adequate action is a key to facilitating the best recovery in patients.


Kassi Jackson

Latest:

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.


Gary W. Jerkins, MD

Latest:

Increasing your practice’s reach, relevance, and revenue with clinical trials

Working as an investigator can prove to be a positive experience for physicians


Rahul T. Pandit, MD

Latest:

The eyes offer conjunctival clue to COVID-19

A patient's vision loss leads to another diagnosis




Dilsher S. Dhoot, MD

Latest:

Future Directions of Retinal Eye Disorders

Dilsher S. Dhoot, MD, and A. Paul Chous, MA, OD, FAAO, discuss future directions and unmet needs in the field of retinal eye disease.


A. Paul Chous, MA, OD, FAAO

Latest:

Future Directions of Retinal Eye Disorders

Dilsher S. Dhoot, MD, and A. Paul Chous, MA, OD, FAAO, discuss future directions and unmet needs in the field of retinal eye disease.


James G. Chelnis, MD

Latest:

Driving practice growth: Expand on link between dry eye, aesthetics

One obvious trend has been that dry eye disease is a concurrent problem for virtually all my patients, and we need to address it for optimum comfort and surgical results.


Dagny Zhu, MD

Latest:

Seasonal allergies: Common trigger for dry eye flares

Short-term steroid use can alleviate patient discomfort.



Howard D. Pomeranz, MD, PhD

Latest:

Protection of eyes during prone positioning must be routinely monitored in ICU

Treatment of patients with COVID-19 should include ophthalmic considerations.


Andrew G. Lee, MD

Latest:

VLOG: Neuro-Ophthalmology interprofessional eConsults

Andrew Lee, MD, Andrew Carey, MD, and Elizabeth Fortin, MD, sit down on this episode of the NeuroOp Guru to discuss neuro-ophthalmology, interprofessional eConsults, and whether they provide timely and valuable guidance


Jon Carter

Latest:

Optic Relief - 2023 Issues

The latest in Optic Relief from Ophthalmology Times

© 2023 MJH Life Sciences

All rights reserved.